David H. Moore

1.6k total citations
34 papers, 1.3k citations indexed

About

David H. Moore is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, David H. Moore has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in David H. Moore's work include Pesticide Exposure and Toxicity (5 papers), Cancer-related Molecular Pathways (5 papers) and DNA Repair Mechanisms (3 papers). David H. Moore is often cited by papers focused on Pesticide Exposure and Toxicity (5 papers), Cancer-related Molecular Pathways (5 papers) and DNA Repair Mechanisms (3 papers). David H. Moore collaborates with scholars based in United States, United Kingdom and Ireland. David H. Moore's co-authors include Mark R. Kelley, Jonathan I. Epstein, Peter R. Carroll, G. Steven Bova, Ronald H. Jensen, Michael L. Cher, William B. Isaacs, Eric J. Small, Sokhom S. Pin and Helen Michael and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

David H. Moore

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Moore United States 15 647 411 261 237 156 34 1.3k
K D Tutsch United States 17 492 0.8× 544 1.3× 152 0.6× 183 0.8× 158 1.0× 22 1.4k
June E. Paciga United States 15 808 1.2× 412 1.0× 450 1.7× 150 0.6× 160 1.0× 22 1.6k
Reiko Makino Japan 23 868 1.3× 501 1.2× 187 0.7× 293 1.2× 226 1.4× 53 1.7k
Nancy Klauber United States 6 854 1.3× 403 1.0× 124 0.5× 293 1.2× 85 0.5× 6 1.5k
Yasuko Nishizawa Japan 19 444 0.7× 233 0.6× 201 0.8× 189 0.8× 102 0.7× 53 1.1k
Verena Materna Germany 20 552 0.9× 632 1.5× 92 0.4× 220 0.9× 96 0.6× 33 1.1k
Wiesława Niklińska Poland 23 577 0.9× 393 1.0× 333 1.3× 271 1.1× 137 0.9× 77 1.3k
A Wakui Japan 16 719 1.1× 708 1.7× 371 1.4× 202 0.9× 245 1.6× 107 1.5k
Miki Shitashige Japan 26 1.1k 1.8× 435 1.1× 215 0.8× 299 1.3× 103 0.7× 43 1.9k
Nilgün Kapucuoğlu Türkiye 20 253 0.4× 304 0.7× 137 0.5× 187 0.8× 223 1.4× 74 1000

Countries citing papers authored by David H. Moore

Since Specialization
Citations

This map shows the geographic impact of David H. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Moore more than expected).

Fields of papers citing papers by David H. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Moore. The network helps show where David H. Moore may publish in the future.

Co-authorship network of co-authors of David H. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Moore. A scholar is included among the top collaborators of David H. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Moore. David H. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berek, Jonathan S., Eva Chalas, Mitchell I. Edelson, et al.. (2010). Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomy. Obstetrics and Gynecology. 116(3). 733–743. 69 indexed citations
2.
Bastian, Boris C., Mohammed Kashani–Sabet, Henning Hamm, et al.. (2000). Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.. PubMed. 60(7). 1968–73. 179 indexed citations
3.
Hurteau, Jean, Gregory P. Sutton, David H. Moore, et al.. (1999). Transforming growth factor-? differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1. Cancer. 85(8). 1810–1815. 10 indexed citations
4.
Moore, David H.. (1998). Long term health effects of low dose exposure to nerve agent. Journal of Physiology-Paris. 92(3-4). 325–328. 11 indexed citations
5.
Moore, David H.. (1998). Health Effects of Exposure to Low Doses of Nerve Agent-a Review of Present Knowledge. Drug and Chemical Toxicology. 21(sup1). 123–130. 16 indexed citations
6.
Schilder, Jeanne M., Jean Hurteau, Katherine Y. Look, et al.. (1997). A Prospective Controlled Trial of Early Postoperative Oral Intake Following Major Abdominal Gynecologic Surgery. Gynecologic Oncology. 67(3). 235–240. 98 indexed citations
7.
Moore, David H., et al.. (1997). Collagenase Expression in Ovarian Cancer Cell Lines. Gynecologic Oncology. 65(1). 78–82. 23 indexed citations
8.
Moore, David H., Kris Ghosh, & Gregory P. Sutton. (1994). Spontaneous Occurrence of Gangrene Due to Clostridium septicum in a Patient With AdvancedEndometrial Carcinoma. Infectious Diseases in Obstetrics and Gynecology. 2(1). 34–37. 2 indexed citations
9.
Ghosh, Kris, David H. Moore, & Gregory P. Sutton. (1994). Epithelial ovarian cancer complicating renal transplantation. American Journal of Obstetrics and Gynecology. 171(1). 276–277. 1 indexed citations
10.
Moore, David H., et al.. (1993). Hexamethylmelamine/Altretamine as Second-Line Therapy for Epithelial Ovarian Carcinoma. Gynecologic Oncology. 51(1). 109–112. 15 indexed citations
11.
Moore, David H., et al.. (1992). Description of a spheroid model for the study of radiation and chemotherapy effects on hypoxic tumor cell populations. Gynecologic Oncology. 47(1). 44–47. 12 indexed citations
12.
Adler, Michael, David H. Moore, & Margaret G. Filbert. (1992). Mechanism of soman-induced contractions in canine tracheal smooth muscle. Archives of Toxicology. 66(3). 204–210. 3 indexed citations
13.
Filbert, Margaret G., David H. Moore, & Michael Adler. (1992). Relaxation of Soman-Induced Contracture of Airway Smooth MuscleIn Vitro. Drug and Chemical Toxicology. 15(3). 203–215.
14.
Moore, David H., et al.. (1991). The Effects of Exercise Following Exposure to Bis(Trefluoromethyl) Disulfide. Drug and Chemical Toxicology. 14(4). 343–352. 1 indexed citations
15.
Moore, David H., Wesley C. Fowler, John L. Currie, & Leslie A. Walton. (1991). Squamous cell carcinoma of the vulva in pregnancy. Gynecologic Oncology. 41(1). 74–77. 7 indexed citations
16.
Moore, David H., et al.. (1991). HI‐6 and 2‐pam in sheep: Pharmacokinetics and effects on muscle tissue following intramuscular injection. Biopharmaceutics & Drug Disposition. 12(3). 223–232. 9 indexed citations
17.
Moore, David H., et al.. (1990). 5-Fluorouracil neurotoxicity. Gynecologic Oncology. 36(1). 152–154. 28 indexed citations
18.
Fowler, Wesley C., et al.. (1988). Significance of multiparameter flow cytometric analysis of ovarian cancer. American Journal of Obstetrics and Gynecology. 158(4). 838–843. 18 indexed citations
19.
Moore, David H., et al.. (1982). The effect of dose and vehicle on early tissue damage and regenerative activity after chloroform administration to mice. Food and Chemical Toxicology. 20(6). 951–954. 18 indexed citations
20.
Moore, David H., et al.. (1976). The metabolism of the antibacterial agent bronopol (2-bromo-2-nitropropane-1,3-diol) given orally to rats and dogs. Food and Cosmetics Toxicology. 14(3). 183–187. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K D Tutsch Breakdown of academic impact, for papers by June E. Paciga Breakdown of academic impact, for papers by Reiko Makino Breakdown of academic impact, for papers by Nancy Klauber Breakdown of academic impact, for papers by Yasuko Nishizawa Breakdown of academic impact, for papers by Verena Materna Breakdown of academic impact, for papers by Wiesława Niklińska Breakdown of academic impact, for papers by A Wakui Breakdown of academic impact, for papers by Miki Shitashige Breakdown of academic impact, for papers by Nilgün Kapucuoğlu
Rankless by CCL
2026